English | Español
Patient Daily | Feb 22, 2026

Ocular Therapeutix’s hydrogel shows stronger results than Eylea in late-stage wet AMD trial
Patient Daily | Feb 22, 2026

Vaxart advances oral norovirus vaccine as rivals face clinical challenges
Patient Daily | Feb 22, 2026

Compass Pathways reports positive phase 3 results for psilocybin-based depression therapy
Patient Daily | Feb 22, 2026

Disc Medicine faces regulatory uncertainty after FDA rejects rare disease drug
Patient Daily | Feb 22, 2026

Biopharma faces rising costs as fetal bovine serum shortages tighten supplies
Patient Daily | Feb 22, 2026

Radiopharma industry boosts efforts to secure actinium‑225 amid growing demand
Patient Daily | Feb 22, 2026

Eli Lilly licenses CSL’s IL-6 antibody in $100M deal amid acquisition spree
Patient Daily | Feb 22, 2026

JAX-NYSCF partners with GSK to improve models for neurodegenerative disease research

Trending
+ Pharmaceuticals
Patient Daily | Mar 4, 2026

Gene therapies for sickle cell disease face slow uptake despite early promise
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others
+ Pharmaceuticals
Patient Daily | Mar 4, 2026

Congress approves record $315 million for ALS research amid new treatment efforts
+ Regulatory
A. B. Abbott | Mar 4, 2026

Rep. Pappas: Proposed federal student loan policy ‘will make it harder for nursing students to access the loans they need’